Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial

OBJECTIVE: To determine the safety and therapeutic effects of nimotuzumab (h-R3) combined with radiotherapy in esophageal cancer. METHODS: This Phase II clinical trial involved 42 patients with stage II (inoperable or refused surgery) to stage IV (supraclavicular lymph node metastasis only) esophage...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Liang, Jun, E, Mingyan, Wu, Gang, Zhao, Lujun, Li, Xia, Xiu, Xia, Li, Ning, Chen, Bo, Hui, Zhouguang, Lv, Jima, Fang, Hui, Tang, Yu, Bi, Nan, Wang, Wenqing, Zhai, Yirui, Li, Tao, Chen, Dongfu, Zou, Shuangmei, Lu, Ning, Perez-Rodríguez, Rolando, Zheng, Junqi, Wang, Luhua
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2013
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3825695/
https://ncbi.nlm.nih.gov/pubmed/24235844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S50945
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller